Industry

Tevogen Bio® and Founding CEO are nominated for the 2023 Nobel Peace Prize by Curtis Patton, PhD, Professor Emeritus, Yale School of Public Health, Yale University WARREN, N.J.–(BUSINESS WIRE)–#celltherapies—Tevogen Bio®, is a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in virology, neurology, and oncology. The company and its founding CEO, Dr. … [Read more…]

Adrian joins team of FitBiomics Athlete Ambassadors that includes Chris Mullin, Lia Neal, Adeline Gray, Krysta Palmer, Tim Parker, Kyle Pietari, Angela Naeth, Marcus Hatten, Peter Schmidt, CJ Albertson, Amanda Coker and Michelle Carter NEW YORK–(BUSINESS WIRE)–FitBiomics, Inc. announced today that it has signed swimming great Nathan Adrian to its roster of elite athlete ambassadors. … [Read more…]

Parental Concern for Anxiety, Panic Attacks and Depression Increased Year Over Year, While 46% Fear a Negative Mental Health Impact from School Safety Issues MADISON, Wis.–(BUSINESS WIRE)–#DOTCommunity–An independent survey of parents sheds new light on the mental health and health care challenges facing children and families in the United States. The survey explores roadblocks to … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that at the 2022 NASS Annual Meeting, the Company will introduce expandable interbody and access technology designed to enhance the medialized minimally-invasive (MIS) posterior approach. The procedure is designed to minimize muscle morbidity and … [Read more…]

New executives bring experience from Google, Skype, Walmart & Amazon SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, has added two high-profile executives to its leadership ranks as the company continues to deliver improving financial performance, … [Read more…]

Clinical Expertise and Advanced Therapies’ Offering Caters to Growing Patient Population Statewide BIRMINGHAM, Ala. & MOBILE, Ala.–(BUSINESS WIRE)–#VirtisHealth—Virtis Health, an innovative, national provider dedicated to therapeutic and diagnostic services for patients with complex conditions requiring specialty infusible and injectable medications, announced today the unveiling of two Ambulatory Infusion Centers (AIC) in Alabama: one in Birmingham … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$JANX—Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the first patient has been dosed in a Phase 1 clinical trial of JANX007 in … [Read more…]

Alice Zhang, Chief Executive Officer and Co-Founder, Among the Most Exceptional Entrepreneurs at 2022 Builders and Innovators Summit SAN FRANCISCO–(BUSINESS WIRE)–Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human data to develop new drugs, announced today that Goldman Sachs (NYSE:GS) is recognizing Verge’s Chief Executive Officer and co-founder, … [Read more…]

AUSTIN, Texas, & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that Senior Management will participate in four upcoming healthcare investor conferences. Oppenheimer Private Company Showcase: The Next Wave: presentation … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, including its lead candidate AD109, today announced that company management will participate in the 2nd Annual Needham Biotech Private Company Virtual 1×1 Forum taking place October 18-19, 2022. Meeting schedules will be accessible … [Read more…]